Virus Replication < Virus Replication (drug effects) < Virus Replication (genetics)

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 130.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000184 (2003)	J. Cinatl [Allemagne] ; B. Morgenstern ; G. Bauer ; P. Chandra ; H. Rabenau ; H W Doerr	Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.
000266 (2003)	J. Cinatl [Allemagne] ; B. Morgenstern ; G. Bauer ; P. Chandra ; H. Rabenau ; H W Doerr	Treatment of SARS with human interferons.
000305 (2003)	Renli Zhang [République populaire de Chine] ; Zhongmin Guo ; Jiahai Lu ; Jinxiu Meng ; Canquan Zhou ; Ximei Zhan ; Bing Huang ; Xinbing Yu ; Min Huang ; Xinghua Pan ; Wenhua Ling ; Xigu Chen ; Zhuoyue Wan ; Huanying Zheng ; Xinge Yan ; Yifei Wang ; Yanchao Ran ; Xinjian Liu ; Junxin Ma ; Chengyu Wang ; Biliang Zhang	Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA.
000468 (2003)	Wenhui Li [États-Unis] ; Michael J. Moore ; Natalya Vasilieva ; Jianhua Sui ; Swee Kee Wong ; Michael A. Berne ; Mohan Somasundaran ; John L. Sullivan ; Katherine Luzuriaga ; Thomas C. Greenough ; Hyeryun Choe ; Michael Farzan	Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
000621 (2004)	Bart L. Haagmans [Pays-Bas] ; Thijs Kuiken ; Byron E. Martina ; Ron A M. Fouchier ; Guus F. Rimmelzwaan ; Geert Van Amerongen ; Debby Van Riel ; Ton De Jong ; Shigeyuki Itamura ; Kwok-Hung Chan ; Masato Tashiro ; Albert D M E. Osterhaus	Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.
000683 (2004)	Lisa E. Hensley [États-Unis] ; Elizabeth A. Fritz [États-Unis] ; Peter B. Jahrling [États-Unis] ; Christopher Karp [États-Unis] ; John W. Huggins [États-Unis] ; Thomas W. Geisbert [États-Unis]	Interferon-β 1a and SARS Coronavirus Replication
000739 (2004)	Dale L. Barnard [États-Unis] ; Valerie D. Hubbard ; Jared Burton ; Donald F. Smee ; John D. Morrey ; Michael J. Otto ; Robert W. Sidwell	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine.
000802 (2004)	Martin Spiegel [Allemagne] ; Andreas Pichlmair ; Elke Mühlberger ; Otto Haller ; Friedemann Weber	The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein.
000813 (2004)	Norio Yamamoto [Japon] ; Rongge Yang [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Shinji Amari [Japon] ; Tatsuya Nakano [Japon] ; Jindrich Cinatl [Allemagne] ; Holger Rabenau [Allemagne] ; Hans Wilhelm Doerr [Allemagne] ; Gerhard Hunsmann [Allemagne] ; Akira Otaka [Japon] ; Hirokazu Tamamura [Japon] ; Nobutaka Fujii [Japon] ; Naoki Yamamoto [Japon]	HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
000836 (2004)	Tobias Hertzig [Allemagne] ; Elke Scandella [Suisse] ; Barbara Schelle [Allemagne] ; John Ziebuhr [Allemagne] ; Stuart G. Siddell [Royaume-Uni] ; Burkhard Ludewig [Suisse] ; Volker Thiel [Suisse]	Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.
000905 (2004)	Chang-Jer Wu [Taïwan] ; Jia-Tsrong Jan ; Chi-Min Chen ; Hsing-Pang Hsieh ; Der-Ren Hwang ; Hwan-Wun Liu ; Chiu-Yi Liu ; Hui-Wen Huang ; Su-Chin Chen ; Cheng-Fong Hong ; Ren-Kuo Lin ; Yu-Sheng Chao ; John T A. Hsu	Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide.
000914 (2004)	Zhi Wang [République populaire de Chine] ; Lili Ren ; Xingang Zhao ; Tao Hung ; Anming Meng ; Jianwei Wang ; Ye-Guang Chen	Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells.
000921 (2004)	Chung-Yi Wu [Taïwan] ; Jia-Tsrong Jan ; Shiou-Hwa Ma ; Chih-Jung Kuo ; Hsueh-Fen Juan ; Yih-Shyun E. Cheng ; Hsien-Hua Hsu ; Hsuan-Cheng Huang ; Douglass Wu ; Ashraf Brik ; Fu-Sen Liang ; Rai-Shung Liu ; Jim-Min Fang ; Shui-Tein Chen ; Po-Huang Liang ; Chi-Huey Wong	Small molecules targeting severe acute respiratory syndrome human coronavirus.
000930 (2004)	Els Keyaerts [Belgique] ; Leen Vijgen [Belgique] ; Luni Chen [Suède, République populaire de Chine] ; Piet Maes [Belgique] ; Göran Hedenstierna [Suède] ; Marc Van Ranst [Belgique]	Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound☆
000945 (2004)	Runtao He [Canada] ; Anton Adonov [Canada] ; Maya Traykova-Adonova [Canada] ; Jingxin Cao [Canada] ; Todd Cutts [Canada] ; Elsie Grudesky [Canada] ; Yvon Deschambaul [Canada] ; Jody Berry [Canada] ; Michael Drebot [Canada] ; Xuguang Li [Canada]	Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid
000982 (2004)	Bojian Zheng [Hong Kong] ; Ming-Liang He ; King-Ling Wong ; Ching Tung Lum ; Leo L M. Poon ; Ying Peng ; Yi Guan ; Marie C M. Lin ; Hsiang-Fu Kung	Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma).
000A38 (2003)	Yue-Long Shu [République populaire de Chine] ; Zhao-Jun Duan ; Zheng Wang ; Mei-Sheng Sun ; Jing Zhang ; Li-Lan Zhang ; Xue-Jun Ma ; Jun-Ping Peng ; Qi Jin ; Yun-De Hou	[Development of the cDNA chip for SARS virus and a primary study on the possible molecular mechanism of interferon alpha2b inhibiting the SARS virus replication].
000A80 (2004)	Richard Y. Kao [République populaire de Chine] ; Wayne H W. Tsui ; Terri S W. Lee ; Julian A. Tanner ; Rory M. Watt ; Jian-Dong Huang ; Lihong Hu ; Guanhua Chen ; Zhiwei Chen ; Linqi Zhang ; Tian He ; Kwok-Hung Chan ; Herman Tse ; Amanda P C. To ; Louisa W Y. Ng ; Bonnie C W. Wong ; Hoi-Wah Tsoi ; Dan Yang ; David D. Ho ; Kwok-Yung Yuen	Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
000B12 (2004)	Bruno Sainz [États-Unis] ; Eric C. Mossel ; C J Peters ; Robert F. Garry	Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
000C66 (2004)	Birgit Morgenstern [Allemagne] ; Martin Michaelis [Allemagne] ; Patrick C. Baer [Allemagne] ; Hans W. Doerr [Allemagne] ; Jindrich Cinatl [Allemagne]	Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
000D27 (2005)	Sara Akerström [Suède] ; Mehrdad Mousavi-Jazi ; Jonas Klingström ; Mikael Leijon ; Ake Lundkvist ; Ali Mirazimi	Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Virus Replication (drug effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Virus Replication (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Virus Replication (drug effects)
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021